Trial Profile
The Effects of Cortisol Blockade on Nutritional Sympathetic Nervous System Responsiveness in Overweight and Obese Subjects With Metabolic Syndrome
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metyrapone (Primary)
- Indications Insulin resistance; Obesity
- Focus Pharmacodynamics
- 16 Jan 2013 Planned initiation date changed from 1 Sep 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 20 Jun 2012 New trial record